A bill to increase the clarity and predictability of the process for developing applications for Rx-to-nonprescription switches.
In committee: it can still change before the session ends.
- Stage
- In committee
- Started in
- Senate
- Sponsors
- 2
- Latest action
- Jul 30, 2025
What it does
The bill aims to increase the clarity and predictability of the process for developing applications to switch prescription drugs to nonprescription (over-the-counter) status. It requires the Secretary of Health and Human Services to issue guidance within 18 months on evidentiary standards, meeting procedures, and the use of additional tools like mobile apps to support such switches, and to develop a public stakeholder engagement plan within one year. The bill also mandates a GAO report evaluating the number of approved switches, review timelines, barriers, and opportunities for collaboration between FDA and CMS on analyzing health insurance data for potential switch candidates. These…
No official summary is available here. This one was written by AI from the bill’s text.
Where it stands
Introduced (Done)
Committee (Current step)
Floor (Not started)
Law (Not started)
What moved
Who is involved
Sponsors
The lawmakers who put their names on it, lead sponsors first.
In the news
Reporting that may mention this subject. Possible matches are labeled.
Loading coverage…
Where it goes next
While a bill can still move, the questions are about people and money.